Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.

Zirngibl RA, Wang A, Yao Y, Manolson MF, Krueger J, Dupuis L, Mendoza-Londono R, Voronov I.

J Cell Biochem. 2019 Oct;120(10):17180-17193. doi: 10.1002/jcb.28979. Epub 2019 May 20.

PMID:
31111556
2.

Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.

Ighani A, Yu AM, Sandhu VK, Barankin B, Manolson MF.

J Cutan Med Surg. 2019 Mar/Apr;23(2):148-156. doi: 10.1177/1203475418808764. Epub 2019 Feb 25.

PMID:
30801221
3.

An Evaluation of Psoriasis Patient Perceptions and Understanding of Biosimilars: A Canadian Survey Comparing Biologic and Nonbiologic Users.

Ighani A, Wang JY, Manolson MF.

J Cutan Med Surg. 2018 May/Jun;22(3):365-367. doi: 10.1177/1203475417746337. Epub 2018 Apr 2. No abstract available.

PMID:
29608867
4.

Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4.

Esmail S, Kartner N, Yao Y, Kim JW, Reithmeier RAF, Manolson MF.

J Biol Chem. 2018 Feb 23;293(8):2787-2800. doi: 10.1074/jbc.M117.818872. Epub 2018 Jan 8.

5.

N-linked glycosylation of a subunit isoforms is critical for vertebrate vacuolar H+ -ATPase (V-ATPase) biosynthesis.

Esmail S, Kartner N, Yao Y, Kim JW, Reithmeier RAF, Manolson MF.

J Cell Biochem. 2018 Jan;119(1):861-875. doi: 10.1002/jcb.26250. Epub 2017 Aug 4.

PMID:
28661051
6.

Controlled bone formation using ultrasound-triggered release of BMP-2 from liposomes.

Crasto GJ, Kartner N, Reznik N, Spatafora MV, Chen H, Williams R, Burns PN, Clokie C, Manolson MF, Peel SA.

J Control Release. 2016 Dec 10;243:99-108. doi: 10.1016/j.jconrel.2016.09.032. Epub 2016 Sep 28.

PMID:
27693545
7.

N-Linked Glycosylation Is Required for Vacuolar H+ -ATPase (V-ATPase) a4 Subunit Stability, Assembly, and Cell Surface Expression.

Esmail S, Yao Y, Kartner N, Li J, Reithmeier RA, Manolson MF.

J Cell Biochem. 2016 Dec;117(12):2757-2768. doi: 10.1002/jcb.25574. Epub 2016 Sep 7.

PMID:
27127844
8.

Editorial: Flt3 ligand-friend or foe?

Voronov I, Manolson MF.

J Leukoc Biol. 2016 Mar;99(3):401-3. doi: 10.1189/jlb.3CE0915-445RR. No abstract available.

PMID:
26932387
9.

Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cells.

Bernard D, Gebbia M, Prabha S, Gronda M, MacLean N, Wang X, Hurren R, Sukhai MA, Cho EE, Manolson MF, Datti A, Wrana J, Minden MD, Al-Awar R, Aman A, Nislow C, Giaever G, Schimmer AD.

Apoptosis. 2015 Jul;20(7):948-59. doi: 10.1007/s10495-015-1123-3.

PMID:
25832785
10.

Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.

Kartner N, Manolson MF.

Expert Opin Drug Discov. 2014 May;9(5):505-22. doi: 10.1517/17460441.2014.902155. Review.

PMID:
24749538
11.

The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.

Ochotny N, Voronov I, Owen C, Aubin JE, Manolson MF.

J Cell Biochem. 2013 Dec;114(12):2823-33. doi: 10.1002/jcb.24630.

PMID:
23908015
12.

VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy.

Ramachandran N, Munteanu I, Wang P, Ruggieri A, Rilstone JJ, Israelian N, Naranian T, Paroutis P, Guo R, Ren ZP, Nishino I, Chabrol B, Pellissier JF, Minetti C, Udd B, Fardeau M, Tailor CS, Mahuran DJ, Kissel JT, Kalimo H, Levy N, Manolson MF, Ackerley CA, Minassian BA.

Acta Neuropathol. 2013 Mar;125(3):439-57. doi: 10.1007/s00401-012-1073-6. Epub 2013 Jan 12.

PMID:
23315026
13.

Topology, glycosylation and conformational changes in the membrane domain of the vacuolar H+-ATPase a subunit.

Kartner N, Yao Y, Bhargava A, Manolson MF.

J Cell Biochem. 2013 Jul;114(7):1474-87. doi: 10.1002/jcb.24489.

PMID:
23296946
14.

Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.

Crasto GJ, Kartner N, Yao Y, Li K, Bullock L, Datti A, Manolson MF.

J Cell Biochem. 2013 Apr;114(4):929-41. doi: 10.1002/jcb.24434.

PMID:
23129004
15.

Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.

Durand M, Komarova SV, Bhargava A, Trebec-Reynolds DP, Li K, Fiorino C, Maria O, Nabavi N, Manolson MF, Harrison RE, Dixon SJ, Sims SM, Mizianty MJ, Kurgan L, Haroun S, Boire G, de Fatima Lucena-Fernandes M, de Brum-Fernandes AJ.

Arthritis Rheum. 2013 Jan;65(1):148-58. doi: 10.1002/art.37722.

16.

The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.

Voronov I, Ochotny N, Jaumouillé V, Owen C, Manolson MF, Aubin JE.

J Bone Miner Res. 2013 Jan;28(1):108-18. doi: 10.1002/jbmr.1727.

17.

Osteopetrosis mutation R444L causes endoplasmic reticulum retention and misprocessing of vacuolar H+-ATPase a3 subunit.

Bhargava A, Voronov I, Wang Y, Glogauer M, Kartner N, Manolson MF.

J Biol Chem. 2012 Aug 3;287(32):26829-39. doi: 10.1074/jbc.M112.345702. Epub 2012 Jun 8.

18.

V-ATPase subunit interactions: the long road to therapeutic targeting.

Kartner N, Manolson MF.

Curr Protein Pept Sci. 2012 Mar;13(2):164-79. Review.

PMID:
22044155
19.

Mouse FLRT2 interacts with the extracellular and intracellular regions of FGFR2.

Wei K, Xu Y, Tse H, Manolson MF, Gong SG.

J Dent Res. 2011 Oct;90(10):1234-9. doi: 10.1177/0022034511415272. Epub 2011 Jul 15.

PMID:
21765038
20.

The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice.

Ochotny N, Flenniken AM, Owen C, Voronov I, Zirngibl RA, Osborne LR, Henderson JE, Adamson SL, Rossant J, Manolson MF, Aubin JE.

J Bone Miner Res. 2011 Jul;26(7):1484-93. doi: 10.1002/jbmr.355.

21.

The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.

Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ.

Bone. 2011 Mar 1;48(3):588-96. doi: 10.1016/j.bone.2010.10.167. Epub 2010 Oct 17.

PMID:
20959150
22.

Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.

Kartner N, Yao Y, Li K, Crasto GJ, Datti A, Manolson MF.

J Biol Chem. 2010 Nov 26;285(48):37476-90. doi: 10.1074/jbc.M110.123281. Epub 2010 Sep 13.

23.

Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.

Gramoun A, Azizi N, Sodek J, Heersche JN, Nakchbandi I, Manolson MF.

J Cell Biochem. 2010 Nov 1;111(4):1020-34. doi: 10.1002/jcb.22791.

PMID:
20672308
24.

Bone matrix proteins and extracellular acidification: potential co-regulators of osteoclast morphology.

Gramoun A, Goto T, Nordström T, Rotstein OD, Grinstein S, Heersche JN, Manolson MF.

J Cell Biochem. 2010 Oct 1;111(2):350-61. doi: 10.1002/jcb.22705.

PMID:
20506338
25.

VEGF-A expression in osteoclasts is regulated by NF-kappaB induction of HIF-1alpha.

Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF.

J Cell Biochem. 2010 May 15;110(2):343-51. doi: 10.1002/jcb.22542.

PMID:
20432243
26.

IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts.

Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF.

J Cell Biochem. 2010 Apr 1;109(5):975-82. doi: 10.1002/jcb.22476.

PMID:
20108252
27.

Molecular markers of early orthodontic tooth movement.

Brooks PJ, Nilforoushan D, Manolson MF, Simmons CA, Gong SG.

Angle Orthod. 2009 Nov;79(6):1108-13. doi: 10.2319/121508-638R.1.

PMID:
19852601
28.

Regulation of vacuolar H(+)-ATPase in microglia by RANKL.

Serrano EM, Ricofort RD, Zuo J, Ochotny N, Manolson MF, Holliday LS.

Biochem Biophys Res Commun. 2009 Nov 6;389(1):193-7. doi: 10.1016/j.bbrc.2009.08.122. Epub 2009 Aug 26.

29.

Expression of nitric oxide synthases in orthodontic tooth movement.

Nilforoushan D, Manolson MF.

Angle Orthod. 2009 May;79(3):502-8. doi: 10.2319/050808-252.1.

PMID:
19413393
30.

Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.

Nilforoushan D, Gramoun A, Glogauer M, Manolson MF.

Nitric Oxide. 2009 Aug;21(1):27-36. doi: 10.1016/j.niox.2009.04.002. Epub 2009 Apr 21.

PMID:
19389479
31.

VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification.

Ramachandran N, Munteanu I, Wang P, Aubourg P, Rilstone JJ, Israelian N, Naranian T, Paroutis P, Guo R, Ren ZP, Nishino I, Chabrol B, Pellissier JF, Minetti C, Udd B, Fardeau M, Tailor CS, Mahuran DJ, Kissel JT, Kalimo H, Levy N, Manolson MF, Ackerley CA, Minassian BA.

Cell. 2009 Apr 17;137(2):235-46. doi: 10.1016/j.cell.2009.01.054. Retraction in: Cell. 2010 Sep 17;142(6):984.

32.

Control of excitatory synaptic transmission by C-terminal Src kinase.

Xu J, Weerapura M, Ali MK, Jackson MF, Li H, Lei G, Xue S, Kwan CL, Manolson MF, Yang K, Macdonald JF, Yu XM.

J Biol Chem. 2008 Jun 20;283(25):17503-14. doi: 10.1074/jbc.M800917200. Epub 2008 Apr 29.

33.

Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-kappaB.

Voronov I, Li K, Tenenbaum HC, Manolson MF.

Biochem Pharmacol. 2008 May 15;75(10):2034-44. doi: 10.1016/j.bcp.2008.02.025. Epub 2008 Feb 29.

PMID:
18396263
34.

Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.

Gramoun A, Shorey S, Bashutski JD, Dixon SJ, Sims SM, Heersche JN, Manolson MF.

J Cell Biochem. 2007 Oct 1;102(2):341-52.

PMID:
17390341
35.

Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases.

Trebec DP, Chandra D, Gramoun A, Li K, Heersche JN, Manolson MF.

J Cell Biochem. 2007 May 1;101(1):205-20.

PMID:
17216600
36.

Effects of human a3 and a4 mutations that result in osteopetrosis and distal renal tubular acidosis on yeast V-ATPase expression and activity.

Ochotny N, Van Vliet A, Chan N, Yao Y, Morel M, Kartner N, von Schroeder HP, Heersche JN, Manolson MF.

J Biol Chem. 2006 Sep 8;281(36):26102-11. Epub 2006 Jul 13.

37.

Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.

Voronov I, Heersche JN, Casper RF, Tenenbaum HC, Manolson MF.

Biochem Pharmacol. 2005 Jul 15;70(2):300-7.

PMID:
15919055
39.

The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or=10 nuclei) and small (<or= nuclei) osteoclasts.

Manolson MF, Yu H, Chen W, Yao Y, Li K, Lees RL, Heersche JN.

J Biol Chem. 2003 Dec 5;278(49):49271-8. Epub 2003 Sep 22.

40.

A novel model system for characterization of phagosomal maturation, acidification, and intracellular collagen degradation in fibroblasts.

Arora PD, Manolson MF, Downey GP, Sodek J, McCulloch CA.

J Biol Chem. 2000 Nov 10;275(45):35432-41.

41.
42.

Alternative mechanisms of vacuolar acidification in H(+)-ATPase-deficient yeast.

Plant PJ, Manolson MF, Grinstein S, Demaurex N.

J Biol Chem. 1999 Dec 24;274(52):37270-9.

43.
44.

Function of the COOH-terminal domain of Vph1p in activity and assembly of the yeast V-ATPase.

Leng XH, Manolson MF, Forgac M.

J Biol Chem. 1998 Mar 20;273(12):6717-23.

45.

Chronic extracellular acidosis induces plasmalemmal vacuolar type H+ ATPase activity in osteoclasts.

Nordström T, Shrode LD, Rotstein OD, Romanek R, Goto T, Heersche JN, Manolson MF, Brisseau GF, Grinstein S.

J Biol Chem. 1997 Mar 7;272(10):6354-60.

46.

Site-directed mutagenesis of the 100-kDa subunit (Vph1p) of the yeast vacuolar (H+)-ATPase.

Leng XH, Manolson MF, Liu Q, Forgac M.

J Biol Chem. 1996 Sep 13;271(37):22487-93. Erratum in: J Biol Chem 1996 Nov 8;271(45):28725.

47.

Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor.

Kim JH, Lingwood CA, Williams DB, Furuya W, Manolson MF, Grinstein S.

J Cell Biol. 1996 Sep;134(6):1387-99.

48.
49.

Interleukin-1 increases vacuolar-type H+-ATPase activity in murine peritoneal macrophages.

Brisseau GF, Grinstein S, Hackam DJ, Nordström T, Manolson MF, Khine AA, Rotstein OD.

J Biol Chem. 1996 Jan 26;271(4):2005-11.

50.

Regulation of cytoplasmic pH in osteoclasts. Contribution of proton pumps and a proton-selective conductance.

Nordström T, Rotstein OD, Romanek R, Asotra S, Heersche JN, Manolson MF, Brisseau GF, Grinstein S.

J Biol Chem. 1995 Feb 3;270(5):2203-12.

Supplemental Content

Loading ...
Support Center